Friday, March 13, 2015 10:27:28 PM
March 6th, 2015 - Vancouver, British Columbia – Vodis Pharmaceuticals Inc. (the “Company” or “Vodis”)
(CSE: VP / FSE: 1JV) announces a non-brokered private placement offering 5,000,000 common shares
("Common Shares") of the Company at a subscription price of $0.10 per share.
In connection with the financing, finders’ fee will comprise 7% cash commission and a 7% finders’
Warrants commission. The proceeds of the private placement will be used for expansion into Washington
State, USA and general working capital purposes.
About Vodis Pharmaceuticals
Vodis is one of Canada’s foremost brand names in the medical marijuana business. While awaiting for the
inspection date from Health Canada to become a Licensed Producer at its state-of-the-art 12,000 square
foot facility in British Columbia, the Vodis management team reinforces its commitment to the Continues
Improvement Process (CIP) by continuously reviewing its internal Standard Operating procedures and
external training of its staff.
http://www.cnsx.ca/cmsAssets/docs/Filings/2015/2015_03_13_19_18_35_VP_Vodis_Pharmaceuticals_Inc_Announces_$500,000_non-brokered_financing.pdf
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM